Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review The ...

A recent update of this original risk stratification scheme addressed not only recurrence, but also prostate-cancer-specific mortality, in an expanded multicenter database of over 7,000 patients ...

Prostate cancer is the most common cancer among men ... to assess the impact of these tissue-based genomic tests on risk stratification and treatment decisions for localized prostate cancer.

THURSDAY, Jan. 9, 2025 (HealthDay News) -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate-specific membrane antigen-positron ...

(HealthDay News) — For patients with localized prostate cancer (PCa), tissue-based genomic ... Prostate Score (GPS), and Prolaris GCs on risk stratification and patient-clinician decisions ...

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

Most patients had one or more metastases when they were diagnosed with prostate cancer. Overall, 9 (11.4 %) and 17 (21.5 %) patients underwent radical prostatectomy and radiation therapy ...